Retrograde Coronary Venous Infusion as a Delivery Strategy in Regenerative Cardiac Therapy: an Overview of Preclinical and Clinical Data

Wouter A. Gathier, Dirk Jan van Ginkel, Mira van der Naald, Frebus J. van Slochteren, Pieter A. Doevendans, Steven A. J. Chamuleau
2018 Journal of Cardiovascular Translational Research  
Study Change in LVEF (%) myocardial perfusion or CCS Follow up timepoint Versus P-value Small animals Di Lascio[1] LVEF: Echocardiopgraphy 12 ± 11.2 % (cells) 16 ± 8.9 % (cells + RLX)
doi:10.1007/s12265-018-9785-1 pmid:29392536 pmcid:PMC5973989 fatcat:denwjdwtgffg3aybuvd56vybuu